Tag: Linnaeus Therapeutics

Linnaeus Therapeutics has filed a notice of an exempt offering of securities to raise $3,920,000.00 in New Equity Investment.

Linnaeus Therapeutics has filed a notice of an exempt offering of securities to raise $3,920,000.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Linnaeus Therapeutics is raising up to $3,920,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Patrick Mooney played a…

Read More Read More

Linnaeus Therapeutics has filed a notice of an exempt offering of securities to raise $3,088,234.00 in New Equity Investment.

Linnaeus Therapeutics has filed a notice of an exempt offering of securities to raise $3,088,234.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Linnaeus Therapeutics is raising $3,088,234.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Patrick Mooney played a key role in…

Read More Read More